Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > MWMan

<< Previous

Bullboard Posts

Next >>

Comment by biorunon May 04, 2023 9:31am

109 Views

Post# 35429644

RE:RE:RE:RE:RE:RE: MWMan

Don't forget about the sglt2 pipeline for both human and animal therapy which has science that is licensing ready and prospective partners at table.

We often discount this, as it has taken time, but it's still very much in play, and it could have significant impact as well.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch